Retrophin
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Retrophin and buy or sell other stocks, ETFs, and their options commission-free!About RTRX
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases.
CEOEric M. Dube, PhD
CEOEric M. Dube, PhD
Employees385
Employees385
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2008
Founded2008
Employees385
Employees385
RTRX Key Statistics
Market cap1.73B
Market cap1.73B
Price-Earnings ratio-31.82
Price-Earnings ratio-31.82
Dividend yield—
Dividend yield—
Average volume1.83M
Average volume1.83M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$37.50
52 Week high$37.50
52 Week low$12.91
52 Week low$12.91
Stock Snapshot
As of today, Retrophin(RTRX) shares are valued at $19.39. The company's market cap stands at 1.73B, with a P/E ratio of -31.82.
On 2025-12-21, Retrophin(RTRX) stock opened at —, reached a high of —, and a low of —.
The Retrophin(RTRX)'s current trading volume is 0, compared to an average daily volume of 1.83M.
During the past year, Retrophin(RTRX) stock moved between $12.91 at its lowest and $37.50 at its peak.
During the past year, Retrophin(RTRX) stock moved between $12.91 at its lowest and $37.50 at its peak.
People also own
Based on the portfolios of people who own RTRX. This list is generated using Robinhood data, and it’s not a recommendation.